Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants

被引：0
|
作者：
Anh, D. D. [1 ]
Thiem, V. D. [1 ]
Hutagalung, Y. [2 ]
Bock, H. L. [2 ]
Suryakiran, P. [2 ]
Delem, A. [2 ]
Han, H. H. [2 ]
机构：
[1] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam
[2] GlaxoSmithKline Biol, Rixensart, Belgium
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.366
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E147 / E147
页数：1
相关论文
共 50 条
  • [1] Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants
    Vesikari, T.
    Karvonen, A.
    Bouckenooghe, A.
    Suryakiran, P. V.
    Smolenov, I.
    Han, H. H.
    [J]. VACCINE, 2011, 29 (11) : 2079 - 2084
  • [2] Immunogenicity of The Oral Live Attenuated Human Rotavirus Vaccine RIX4414 (Rotarix™) Oral Suspension (Liquid Formulation) Co-administered with Childhood Vaccinations in Panama
    Velasquez, A. A.
    Dominguez, E.
    Suryakiran, P. V.
    Delem, A.
    Ortega-Barria, E.
    Han, H. H.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E148 - E148
  • [3] Rotarix™ (RIX4414):: an oral human rotavirus vaccine
    O'Ryan, Miguel
    [J]. EXPERT REVIEW OF VACCINES, 2007, 6 (01) : 11 - 19
  • [4] Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants
    Narang, Anil
    Bose, Anuradha
    Pandit, Anand Nilkanth
    Dutta, Phalguni
    Kang, Gagandeep
    Bhattacharya, Sujit Kumar
    Datta, Sanjoy Kumar
    Suryakiran, P. V.
    Delem, Andree
    Han, Htay Htay
    Bock, Hans Ludwig
    [J]. HUMAN VACCINES, 2009, 5 (06): : 414 - 419
  • [5] Comparison of 2 Different Regimens for Reactogenicity, Safety, and Immunogenicity of the Live Attenuated Oral Rotavirus Vaccine RIX4414 Coadministered with Oral Polio Vaccine in South African Infants
    Steele, A. D.
    Reynders, J.
    Scholtz, F.
    Bos, P.
    de Beer, M. C.
    Tumbo, J.
    Van der Merwe, C. F.
    Delem, A.
    De Vos, B.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 202 : S93 - S100
  • [6] Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants
    Vesikari, T
    Karvonen, A
    Korhonen, T
    Espo, M
    Lebacq, E
    Forster, J
    Zepp, F
    Delem, A
    De Vos, B
    [J]. VACCINE, 2004, 22 (21-22) : 2836 - 2842
  • [7] RIX4414 (RotarixTM):: a live attenuated human rotavirus vaccine
    Bernstein, David I.
    [J]. JORNAL DE PEDIATRIA, 2007, 83 (03) : 193 - 195
  • [8] Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants
    Vesikari, T
    Karvonen, A
    Puustinen, L
    Zeng, SQ
    Szakal, ED
    Delem, A
    De Vos, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (10) : 937 - 943
  • [9] Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
    Li, Rong-cheng
    Huang, Teng
    Li, Yanping
    Wang, Lao-Hong
    Tao, Junhui
    Fu, Botao
    Si, Guoai
    Nong, Yi
    Mo, Zhaojun
    Liao, XueYan
    Luan, Ivy
    Tang, Haiwen
    Rathi, Niraj
    Karkada, Naveen
    Han, Htay Htay
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 785 - 793
  • [10] Efficacy, Immunogenicity and Safety of a Human Rotavirus Vaccine RIX4414 in Singaporean Infants
    Phua, Kong Boo
    Lim, Fong Seng
    Quak, Seng Hock
    Lee, Bee Wah
    Teoh, Yee Leong
    Suryakiran, Pemmaraju V.
    Han, Htay Htay
    Bock, Hans L.
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2016, 45 (02) : 44 - 50
12345